Neuromodulation Market is Expected to Reach $11.0 Billion | MarketsandMarkets™


Chicago, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Neuromodulation market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at a CAGR of 12.0% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. The neuromodulation market is driven by increasing focus on the development of advanced neuromodulation and neurostimulation technologies, rising prevalence of neurological disorders and nerve injuries, government support for research on neurological disorders, availability of reimbursement of neuromodulation devices, collaborations among device manufacturers, healthcare providers, and research institutions to develop neuromodulation devices.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=921

Neuromodulation Market Scope:

Report CoverageDetails
Market Revenue in 2023$6.2 billion
Estimated Value by 2028$11.0 billion
Growth RatePoised to grow at a CAGR of 12.0%
Market Size Available for2021–2028
Forecast Period2023–2028
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredType, application, and region
Geographies CoveredNorth America, Europe, Asia Pacific, and Rest of the World
Report HighlightsUpdated financial information / product portfolio of players
Key Market OpportunityLarge population and increasing healthcare expenditure in emerging countries
Key Market DriverIncreasing focus on the development of advanced neuromodulation and neurostimulation technologies

The rising incidences of neurological diseases across the globe have increased significantly. Neuromodulation is used to treat and improve the quality of life of individuals suffering from chronic illness.

On the basis of type, neuromodulation market is segmented into internal neuromodulation and external neuromodulation. In 2022, internal neuromodulation accounted for the largest share of the global neuromodulation market. This growth can be mainly attributed to reduction of post-surgical complications, reduced hospitalizations, and long-term cost savings associated with internal neuromodulation devices.

The internal neuromodulation market is further categorized into sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, deep brain stimulation, and gastric electrical stimulation. The spinal cord stimulation segment accounted for the largest share of the neuromodulation market in 2022, owing to the increasing number of people suffering from failed back surgery syndrome, ischemia, and chronic pain as well as the favorable reimbursement scenario for spinal cord stimulation.

The external neuromodulation market is segmented into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES). In 2022, transcutaneous electrical nerve stimulation will dominate the external neuromodulation market. This is mainly due to the higher prevalence of depression, its chronic and recurrent nature, and the life-shortening effects of this disease, which have created a demand for TENS therapy.

Based on application, the neuromodulation market has been segmented into vagus nerve stimulation, spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, and transcranial magnetic stimulation. The neuromodulation market for Spinal cord stimulation by application is further segmented into chronic pain, failed back syndrome and ischemia. In 2022, chronic pain applications dominated neuromodulation market. This growth can mainly be attributed to the growing aging population and subsequent increase in prevalence of neurological disorders.

The neuromodulation market is categorized into four major regions: North America, Europe, the Asia Pacific, and Rest of the World. The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the increasing public and private investments, increasing incidence of neurological disorders and ongoing research.

Buy a Neuromodulation Industry Report (210 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=921

Neuromodulation market major players covered in the report, such as:

  • Medtronic (Ireland)
  • Boston Scientific Corporation (US)
  • Abbott Laboratories (US)
  • LivaNova (UK)
  • NeuroPace (US)
  • Neuronetics (US)
  • Helius Medical Technologies (US)
  • Renishaw (UK)
  • GTX Medical (Netherlands)
  • Bioinduction (UK)
  • Axonics (US)
  • Nevro Corporation (US)
  • Nalu Medical (US)
  • Aleva Neurotherapeutics (Switzerland)
  • GiMer Medical (Taiwan)
  • Magtism (UK)
  • NeuroSigma (US)
  • BioWaveGo USA (US)
  • Synapse Biomedical (US)
  • BIOTRONIK (Germany)
  • Theranica Bio-Electronics (Israel)
  • MicroTransponder (US)
  • Soterix Medical (US)
  • Saluda Medical (US)
  • Electrocore Inc. (US)
  • tVNS Technologies (Germany)
  • and Among Others

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=921

This report categorizes the neuromodulation market into the following segments and subsegments:

By Type

  • Internal Neuromodulation
    • Spinal Cord Stimulation
    • Deep Brain Stimulation
    • Vagus Nerve Stimulation
    • Sacral Nerve Stimulation
    • Gastric Electrical Stimulation
  • External Neuromodulation
    • Transcutaneous Electrical Nerve Stimulation (TENS)
    • Transcranial Magnetic Stimulation (TMS)
    • Respiratory Electrical Stimulation (RES)

By Application

  • Spinal Cord Stimulation Market, By Application
    • Failed Back Syndrome
    • Chronic Pain
    • Ischemia
  • Deep Brain Stimulation Market, By Application
    • Parkinson’s Disease
    • Tremor
    • Depression
    • Other DBS Applications
  • Sacral Nerve Stimulation Market, By Application
    • Urine Incontinence
    • Fecal Incontinence
  • Vagus Nerve Stimulation Market, By Application
    • Epilepsy
    • Other VNS Applications
  • Gastric Electrical Stimulation Market, By Application
    • Gastroparesis
    • Obesity
  • Transcutaneous Electrical Nerve Stimulation Market, By Application
    • Treatment-resistant Depression
    • Other TENS Applications
  • Transcranial Magnetic Stimulation Market, By Application
    • Depression
    • Migraine Headache
  • Respiratory Electrical Stimulation Market, By Application
    • Spinal Cord Injury

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East and Africa (Excluding GCC countries)
    • GCC Countries

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=921

Key Market Stakeholders:

  • Manufacturers and distributors of neuromodulation products
  • Pharmaceutical and Biotechnology Companies
  • R & D centers
  • Diagnostic laboratories
  • Hospitals and clinics
  • Academic institutes
  • Research institutes
  • Market research and consulting firms

Report Objectives:

  • To define, describe, segment, and forecast the global neuromodulation market by type, sample, application, and region.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, challenges, and trends)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall neuromodulation market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to four regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

Related Reports:

Nuclear Medicine Market

Defibrillator Market

Nerve Repair & Regeneration Market

ENT Devices Market

Surgical Imaging Market

Research Insights: https://www.marketsandmarkets.com/ResearchInsight/neurostimulation-devices-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/neurostimulation-devices.asp

 

Kontaktdaten